WallStSmart

Cardinal Health Inc (CAH)vsEDAP TMS SA (EDAP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Cardinal Health Inc generates 383412% more annual revenue ($244.67B vs $63.80M). CAH leads profitability with a 0.7% profit margin vs -30.8%. CAH appears more attractively valued with a PEG of 1.33. CAH earns a higher WallStSmart Score of 53/100 (C-).

CAH

Buy

53

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 8.7Quality: 5.8
Piotroski: 4/9Altman Z: 4.30

EDAP

Avoid

23

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 4.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CAHUndervalued (+14.8%)

Margin of Safety

+14.8%

Fair Value

$263.37

Current Price

$211.31

$52.06 discount

UndervaluedFair: $263.37Overvalued

Intrinsic value data unavailable for EDAP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CAH2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.3010/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
18.8%8/10

18.8% revenue growth

EDAP0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CAH4 concerns · Avg: 3.3/10
P/E RatioValuation
29.8x4/10

Moderate valuation

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.7%3/10

0.7% margin — thin

Operating MarginProfitability
1.2%3/10

Operating margin of 1.2%

EDAP4 concerns · Avg: 2.3/10
Market CapQuality
$134.99M3/10

Smaller company, higher risk/reward

PEG RatioValuation
90.472/10

Expensive relative to growth rate

Return on EquityProfitability
-59.5%2/10

ROE of -59.5% — below average capital efficiency

EPS GrowthGrowth
-62.2%2/10

Earnings declined 62.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : CAH

The strongest argument for CAH centers on Altman Z-Score, Revenue Growth. Revenue growth of 18.8% demonstrates continued momentum. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bull Case : EDAP

EDAP has a balanced fundamental profile.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.7% margins leave little buffer for downturns.

Bear Case : EDAP

The primary concerns for EDAP are Market Cap, PEG Ratio, Return on Equity.

Key Dynamics to Monitor

CAH profiles as a growth stock while EDAP is a turnaround play — different risk/reward profiles.

CAH carries more volatility with a beta of 0.62 — expect wider price swings.

CAH is growing revenue faster at 18.8% — sustainability is the question.

CAH generates stronger free cash flow (555M), providing more financial flexibility.

Bottom Line

CAH scores higher overall (53/100 vs 23/100) and 18.8% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

EDAP TMS SA

HEALTHCARE · MEDICAL DISTRIBUTION · USA

EDAP TMS SA, develops, produces, markets, distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States and internationally. The company is headquartered in Lyon, France.

Want to dig deeper into these stocks?